WRNA:XETRA:XETRA-WisdomTree BioRevolution UCITS ETF - USD Acc (EUR)

ETF | Others |

Last Closing

USD 16.026

Change

0.00 (0.00)%

Market Cap

USD 2.77M

Volume

65.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing WRNA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.62% 8% B- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.62% 8% B- 19% F
Trailing 12 Months  
Capital Gain 4.79% 22% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.79% 22% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -5.66% N/A N/A 11% F
Dividend Return -5.66% N/A N/A 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.57% N/A N/A 76% C+
Risk Adjusted Return -74.84% N/A N/A 7% C-
Market Capitalization 2.77M 2% F 2% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.